![Wouter Joustra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wouter Joustra
Directeur/Membre du Conseil chez
ENGENE THERAPEUTICS INC.
Fortune : - $ au 31/05/2026
Profil
Mr. Wouter Joustra is an Independent Director at Vor Biopharma, Inc., an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV, an Independent Director at enGene Therapeutics, Inc. and a General Partner at Forbion Capital Partners Management Holding BV.
He is on the Board of Directors at Vor Biopharma, Inc., NewAmsterdam Pharma Co. NV, enGene Therapeutics, Inc., Beacon Therapeutics Ltd., Navigator Medicines, Inc., VectorY BV and Verdiva Bio, Inc. Mr. Joustra was previously employed as an Independent Director by VectivBio Holding AG, a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, a Non-Independent Director by Forbion European Acquisition Corp., and an Executive Director-Life Sciences Franchise by Kempen & Co. USA, Inc. He also served on the board at VectivBio AG, Aiolos Bio, Inc. and Gyroscope Therapeutics Ltd. He received his undergraduate degree from the University of Nebraska, an undergraduate degree from the University of Groningen and a graduate degree from the University of Groningen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
VOR BIOPHARMA, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Wouter Joustra
| Sociétés | Poste | Début |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur/Membre du Conseil | 15/05/2024 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Directeur/Membre du Conseil | 16/07/2024 |
| VOR BIOPHARMA INC. | Directeur/Membre du Conseil | 18/12/2025 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01/10/2019 |
Beacon Therapeutics Ltd.
 Beacon Therapeutics Ltd. Medical/Nursing ServicesHealth Services Operates as an ophthalmic gene therapy company | Directeur/Membre du Conseil | - |
VectorY BV
 VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Wouter Joustra
| Sociétés | Poste | Fin |
|---|---|---|
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Directeur/Membre du Conseil | 01/12/2023 |
| ENGE HLDGNPV | Directeur/Membre du Conseil | 01/10/2023 |
| VECTIVBIO HOLDING AG | Directeur/Membre du Conseil | 26/06/2023 |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Wouter Joustra
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kempen & Co. USA, Inc.
 Kempen & Co. USA, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
VectorY BV
VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Forbion European Acquisition Corp.
 Forbion European Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Beacon Therapeutics Ltd.
Beacon Therapeutics Ltd. Medical/Nursing ServicesHealth Services Operates as an ophthalmic gene therapy company | Health Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
